Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Average Rating of “Hold” from Analysts

Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) have been assigned a consensus recommendation of “Hold” from the ten research firms that are covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $10.1875.

A number of analysts recently issued reports on the company. UBS Group raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock a “neutral” rating in a research report on Friday, November 7th. Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the stock a “sector perform” rating in a research note on Friday, October 24th. Barclays upgraded shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $5.50 to $9.50 in a report on Tuesday, August 19th. JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their target price for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Finally, BMO Capital Markets began coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They set an “outperform” rating and a $11.00 target price for the company.

Insider Buying and Selling

In other news, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business’s stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total value of $75,114,531.00. Following the completion of the sale, the insider owned 20,544,696 shares in the company, valued at approximately $184,902,264. The trade was a 28.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Paul R. Vigano sold 10,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the transaction, the insider directly owned 386,284 shares in the company, valued at approximately $3,476,556. The trade was a 96.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,597,968 shares of company stock valued at $293,381,712 over the last quarter. 7.80% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. Summit Partners L P acquired a new stake in Aveanna Healthcare in the second quarter worth about $50,477,000. AustralianSuper Pty Ltd acquired a new stake in shares of Aveanna Healthcare during the third quarter worth about $15,743,000. Vanguard Group Inc. increased its stake in shares of Aveanna Healthcare by 34.7% in the third quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company’s stock worth $35,850,000 after acquiring an additional 1,041,324 shares during the period. Hillsdale Investment Management Inc. acquired a new stake in Aveanna Healthcare during the 3rd quarter worth about $7,922,000. Finally, Assenagon Asset Management S.A. purchased a new stake in shares of Aveanna Healthcare in the third quarter worth about $7,356,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Stock Performance

Shares of NASDAQ:AVAH opened at $9.32 on Friday. The firm has a fifty day simple moving average of $9.03 and a two-hundred day simple moving average of $6.90. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a market capitalization of $1.95 billion, a P/E ratio of 25.88 and a beta of 2.04. Aveanna Healthcare has a 52 week low of $3.67 and a 52 week high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The firm had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. On average, analysts expect that Aveanna Healthcare will post -0.06 earnings per share for the current fiscal year.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.